世界科技研究与发展
世界科技研究與髮展
세계과기연구여발전
WORLD SCI-TECH R & D
2013年
6期
733-735
,共3页
杨萍%郑之琬%李浇%郑小波
楊萍%鄭之琬%李澆%鄭小波
양평%정지완%리요%정소파
犬%高危穿透性角膜移植术%1%RAPA%TNF-α
犬%高危穿透性角膜移植術%1%RAPA%TNF-α
견%고위천투성각막이식술%1%RAPA%TNF-α
canine%high-risk PKP%1%RAPA%TNF-α
目的:通过观察肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)变化情况,评价犬高危穿透性角膜移植后RAPA滴眼液抗免疫排斥反应效果。方法选择36只健康犬建立角膜高危病理模型后进行高危穿透性角膜移植手术,并分组用复方氯化钠或1%RAPA点眼,4次/d,18只未手术犬为空白对照组。同时进行外周血和角膜组织中TNF-α含量检测。结果术后7~42 d复方氯化钠组和治疗组TNF-α浓度明显比对照组高(P<0.01),在术后28 d治疗组TNF-α浓度逐渐降低,复方氯化钠组仍维持较高含量。结论 RAPA滴眼液能降低角膜移植手术后TNF-α含量,有效抗免疫排斥反应。
目的:通過觀察腫瘤壞死因子-α(tumor necrosis factor-α,TNF-α)變化情況,評價犬高危穿透性角膜移植後RAPA滴眼液抗免疫排斥反應效果。方法選擇36隻健康犬建立角膜高危病理模型後進行高危穿透性角膜移植手術,併分組用複方氯化鈉或1%RAPA點眼,4次/d,18隻未手術犬為空白對照組。同時進行外週血和角膜組織中TNF-α含量檢測。結果術後7~42 d複方氯化鈉組和治療組TNF-α濃度明顯比對照組高(P<0.01),在術後28 d治療組TNF-α濃度逐漸降低,複方氯化鈉組仍維持較高含量。結論 RAPA滴眼液能降低角膜移植手術後TNF-α含量,有效抗免疫排斥反應。
목적:통과관찰종류배사인자-α(tumor necrosis factor-α,TNF-α)변화정황,평개견고위천투성각막이식후RAPA적안액항면역배척반응효과。방법선택36지건강견건립각막고위병리모형후진행고위천투성각막이식수술,병분조용복방록화납혹1%RAPA점안,4차/d,18지미수술견위공백대조조。동시진행외주혈화각막조직중TNF-α함량검측。결과술후7~42 d복방록화납조화치료조TNF-α농도명현비대조조고(P<0.01),재술후28 d치료조TNF-α농도축점강저,복방록화납조잉유지교고함량。결론 RAPA적안액능강저각막이식수술후TNF-α함량,유효항면역배척반응。
Objective Observe the Changes of TNF-αby 1%RAPA eye drops after high-risk penetrativity penetrating keratoplasty in canine, evaluate the effect of coping immune rejection of RAPA eye drops.Methods Thirty-six healthy local dogs were chosen as participants to estab-lish high-risk pathologic model,and then dealed with high-risk penetrativity penetrating keratoplasty,after grouping,CoNacl or 1%RAPA eye drops were used 4 times in each day.Meanwhile,the content of TNF-αin Peripheral blood and corneal tissue were measured.Results the concentration of TNF-αin CoNacl group and treatment group were obviously higher than control group(P<0.01)on 7th ~42th day after PKP,and on 28th day,the concentration of TNF-αin treatment group was gradually reduced,but in CoNacl group,it was still high.Conclu-sion RAPA could reduce the content of TNF-αafter high-risk penetrativity penetrating keratoplasty and played an effective role of coping im-mune rejection.